Virology Specimen Collection Market Size, Share & Segmentation by Product Type (Swabs, Viral Transport Media, Blood Collection Kits), By Application (Diagnostics, Research), By End User (Hospitals & Clinics, Diagnostic Centers), by Regions and Global Forecast 2023-2030
Report Id: SNS/HC/2443 | July 2022 | Region: Global | 131 Pages
Report Scope & Overview:
The Virology Specimen Collection Market Size was valued at USD 5.81 billion in 2022, and is expected to reach USD 9.19 billion by 2030, and grow at a CAGR of 5.9% over the forecast period 2023-2030.
The collecting of samples from viral specimens is crucial for laboratory diagnosis. The validity of the sample taken will aid in the identification of a certain ailment. Therefore, it is crucial that the sample is taken in a sufficient quantity and in an aseptic manner. The rising prevalence of lifestyle diseases is a major driver of the global market for virology specimen collecting. In addition, rising disposable incomes and people's capacity to spend more on healthcare and medical services will support the expansion of the global market for virology specimen collecting. Additionally, this is anticipated to assist this industry in continuing to generate sizable profits in the forecasted period.
MARKET DYNAMICS
DRIVERS
-
Virus-related illnesses are becoming more common, and new viruses are emerging.
-
More people are giving blood
-
Approval of detection test procedures by regulatory authorities
RESTRAINTS
-
Alternative technology requirements
-
Technologies for collecting virology specimens are expensive.
OPPORTUNITIES
-
Advances in technology
-
Possibilities for financial gain in developing nations
CHALLENGES
-
Technology and collecting kit prices are very high.
-
Application of Low Sensitivity Screening
IMPACT OF COVID-19
The COVID-19 pandemic has greatly expanded drug creation and research activities, putting additional strain on the healthcare sector. However, the pandemic's first effects were detrimental, causing a lack of some goods. Due to the COVID-19 public health emergency, there were substantial disruptions in the vendor supply chains, and testing kits were in higher demand. The market has benefited from increased efforts made by numerous public and private groups to maximize product supply and output. It is envisaged that these partnerships between government agencies and business stakeholders will be extremely beneficial to manufacturers all over the world and encourage market expansion.
VALUE CHAIN ANALYSIS
The market for virology specimen collection is expected to increase significantly over the course of the forecast period. This is explained by the increase in blood donations, the incidence of viral infections, and government licensing of novel and sophisticated detection methods. Additionally, the COVID-19 outbreak-related spike in demand for collecting samples kits across the globe has added to the market's expansion. The market's value chain analysis is made up of five key elements: research & product design, product production, distribution & sales, and post-marketing surveillance. New models and designs are added during the research and product development stages to improve and increase the efficiency of the devices, with the primary goal of manufacturers being to design for patient comfort. The assembling of raw materials is the first step in the production process. After speedy manufacturing, the product is tested for comfort, accuracy, and safety. In the analysis of the market value chain, distribution and sales are essential components. It includes avenues for direct selling as well as intermediaries. The importance of post-sales monitoring in this sector cannot be overstated. The follow-up phase provides information on product sales and aids in understanding any product limits or user comments.
By Product Type
Swabs: Swabs are tiny, pliable bits of material that are used to clean cuts or to remove a tiny sample of a substance from the body or the substance itself so that it may be evaluated. Sterile swabs for upper respiratory specimen collection can be packaged in two different ways, including individually wrapped and bulk packaged, according to research released by the Centers for Disease Control and Prevention (CDC).
Swabs from the back of the nose and throat are known as nasopharyngeal (NP) swabs and are used to collect clinical test samples of nasal secretions. The fastest segment growth is in this one.
Swabs from the oropharynx are known as oropharyngeal (OP) swabs, and they are used to detect bacteria or viruses that could infect the throat.
Viral Transport Media: A swab and a tube of transport media are included in a package called a viral transport media.
Kits for collecting blood: Medical professionals can collect blood samples with the blood collection kit to identify diseases.
Other: A different product category is specimen collection. This is the procedure for gathering fluids or for laboratory analysis or testing close to a patient.
By Application
The virology specimen collection kit allows samples to be taken from the patient's nose using an approved self-collection kit that contains nasal swabs and saline to identify the disease or condition based on the person's symptoms and signs.
Research: To conduct research for the introduction of vaccinations or drugs for illness prevention, samples from patients are collected using virology specimen collection kits. The sector with the fastest growth is this one.
By End User
The virology specimen collection kit allows samples to be taken from the patient's nose using an approved self-collection kit that contains nasal swabs and saline to identify the disease or condition based on the person's symptoms and signs.
Research: To conduct research for the introduction of vaccinations or drugs for illness prevention, samples from patients are collected using virology specimen collection kits. The sector with the fastest growth is this one.
COMPETITIVE LANDSCAPE
Some of the major key players are as follows: BNTX Inc., COPAN Diagnostics, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Medline Industries, Inc., Hardy Diagnostics, Lucence Diagnostics Pte Ltd., VIRCELL S.L., Thermo Fisher Scientific, Inc., Form labs, Puritan Medical Products, and other players.
MARKET SEGMENTS:
By Product Type
-
Swabs
-
Viral Transport Media
-
Blood Collection Kits
By Application
-
Diagnostics
-
Research
By End User
-
Hospitals & Clinics
-
Diagnostic Centers
REGIONAL ANALYSIS
The market for collecting virology specimens has been divided into five main geographic areas: North America, Europe, Asia Pacific, and the Rest of the World. The greatest regional market for the collecting of virology specimens was North America. The high prevalence of TTIs, increased NAT implementation, and technological advancements such portable diagnostics are all responsible for North America's significant market dominance.
REGIONAL COVERAGE:
-
North America
-
USA
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
The Netherlands
-
Rest of Europe
-
-
Asia-Pacific
-
Japan
-
south Korea
-
China
-
India
-
Australia
-
Rest of Asia-Pacific
-
-
The Middle East & Africa
-
Israel
-
UAE
-
South Africa
-
Rest of Middle East & Africa
-
-
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
-
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 5.81 Billion |
| Market Size by 2030 | US$ 9.19 Billion |
| CAGR | CAGR of 5.9% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • by Product Type (Swabs, Viral Transport Media, Blood Collection Kits) • By Application (Diagnostics, Research) • By End User (Hospitals & Clinics, Diagnostic Centers) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | BNTX Inc., COPAN Diagnostics, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Medline Industries, Inc., Hardy Diagnostics, Lucence Diagnostics Pte Ltd., VIRCELL S.L., Thermo Fisher Scientific, Inc., Form labs, Puritan Medical Products, and other players. |
| Key Drivers | • More people are giving blood • Approval of detection test procedures by regulatory authorities |
| RESTRAINTS | • Alternative technology requirements • Technologies for collecting virology specimens are expensive. |
Frequently Asked Questions (FAQ) :
What was the size of Virology Specimen Collection Market in 2021?
Ans. Virology Specimen Collection Market Size was valued at USD 5.49 billion in 2021.
What are the main drivers of the Virology Specimen Collection market?
Ans More people are giving blood, and Approval of detection test procedures by regulatory authorities are the key drivers of the Virology Specimen Collection market.
Which Region is dominating in the Virology Specimen Collection market?
Ans. The greatest regional market for the collecting of virology specimens was North America.
Which are the key players of Virology Specimen Collection market?
Ans. BNTX Inc., COPAN Diagnostics, Becton, Dickinson and Company, Laboratory Corporation of America Holdings are the key players of Virology Specimen Collection market
Who are the buyers of this report?
Ans. Manufacturer and service provider, research institutes, university and private libraries, suppliers and distributers.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Virology Specimen Collection Market Segmentation, By Product Type
8.1 Swabs
8.2 Viral Transport Media
8.3 Blood Collection Kits
9. Virology Specimen Collection Market Segmentation, By Application
9.1 Diagnostics
9.2 Research
10. Virology Specimen Collection Market Segmentation, By End User
10.1 Hospitals & Clinics
10.2 Diagnostic Centers
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12.Company Profiles
12.1 BNTX Inc.
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 COPAN Diagnostics
12.4 Becton, Dickinson and Company
12.5 Laboratory Corporation of America Holdings
12.6 Medline Industries, Inc.
12.7 Hardy Diagnostics
12.8 Lucence Diagnostics Pte Ltd.
12.9 VIRCELL S.L.
12.10 Thermo Fisher Scientific, Inc.
13.Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share analysis
13.3 Recent Developments
14.Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
